ZA978196B - Tricyclic indazole derivates, their preparation and their therapeutic application. - Google Patents

Tricyclic indazole derivates, their preparation and their therapeutic application.

Info

Publication number
ZA978196B
ZA978196B ZA9708196A ZA978196A ZA978196B ZA 978196 B ZA978196 B ZA 978196B ZA 9708196 A ZA9708196 A ZA 9708196A ZA 978196 A ZA978196 A ZA 978196A ZA 978196 B ZA978196 B ZA 978196B
Authority
ZA
South Africa
Prior art keywords
derivates
preparation
therapeutic application
tricyclic indazole
indazole
Prior art date
Application number
ZA9708196A
Inventor
Luc Even
Michel Aletru
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA978196B publication Critical patent/ZA978196B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9708196A 1996-09-12 1997-09-11 Tricyclic indazole derivates, their preparation and their therapeutic application. ZA978196B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9611116A FR2753196B1 (en) 1996-09-12 1996-09-12 TRICYCLIC INDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
ZA978196B true ZA978196B (en) 1998-03-03

Family

ID=9495672

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708196A ZA978196B (en) 1996-09-12 1997-09-11 Tricyclic indazole derivates, their preparation and their therapeutic application.

Country Status (5)

Country Link
AR (1) AR009556A1 (en)
AU (1) AU4211997A (en)
FR (1) FR2753196B1 (en)
WO (1) WO1998011112A1 (en)
ZA (1) ZA978196B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
FR2769915B1 (en) * 1997-10-21 2000-10-13 Synthelabo TRICYCLIC INDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
IL141236A0 (en) * 1998-08-21 2002-03-10 Novartis Ag New oral formulations for 5-ht4 agonists or antagonists
WO2007120599A2 (en) * 2006-04-12 2007-10-25 Wyeth Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
WO2015006193A1 (en) * 2013-07-08 2015-01-15 Incyte Corporation Tricyclic heterocycles as bet protein inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950759A (en) * 1988-07-07 1990-08-21 Duphar International Research B.V. Substituted 1,7-annelated 1H-indazoles
FR2710915B1 (en) * 1993-10-04 1995-11-24 Synthelabo Piperidine derivatives, their preparation and their therapeutic use.

Also Published As

Publication number Publication date
WO1998011112A1 (en) 1998-03-19
FR2753196A1 (en) 1998-03-13
AU4211997A (en) 1998-04-02
FR2753196B1 (en) 1998-10-23
AR009556A1 (en) 2000-04-26

Similar Documents

Publication Publication Date Title
AU1393000A (en) 1,4-diazabicyclo(3.2.2)nonane derivatives, their preparation and therapeutic application
ZA987844B (en) Therapeutic combinations.
WO1998016507A3 (en) New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases
ZA9711029B (en) Therapeutic agents.
ZA987839B (en) Combination therapy.
HUP9801139A3 (en) Polysiloxane-polyol macromers, their preparation and their use
HK1018780A1 (en) 6-Phenylpyridine-2-ylamine derivatives, the composition and use thereof.
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
HUP9904104A3 (en) Derivates from piperidine-keto acid,their preparation and use
ZA964711B (en) Novel compounds, the preparation and use thereof.
ZA200003706B (en) Cyclobutene derivatives, their preparation and their therapeutic uses.
ZA9711169B (en) Pyrrole derivatives, their preparation and pharmaceutical compositions containing them.
IL129927A0 (en) 1,4-Diazabicyclo (2.2.2) oct-2-ylmethyl derivatives their preparation and therapeutic application
HK1001286A1 (en) Benzopyrans and their use as therapeutic agents.
ZA9711168B (en) New therapeutic application of pyrrole derivatives.
SG49971A1 (en) Dye mixtures, proccessing for their preparation and their use
ZA978196B (en) Tricyclic indazole derivates, their preparation and their therapeutic application.
MXPA01011720A (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods.
ZA976619B (en) Benzimidazole derivatives, their preparation and their therapeutic applications.
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
AU5557698A (en) Novel calpaines, their preparation and use
AU1621697A (en) UV absorbers, their preparation and use
EP0826686A3 (en) Tricyclic compounds, their production and use
ZA975771B (en) 1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, their preparation and their therapeutic application.
GB2284603B (en) Sesquiterpenes,their preparation and their use as inhibitors acting on the GABA-benzodiazepine receptor